Barrington raised the firm’s price target on Adtalem Global Education to $90 from $70 and keeps an Outperform rating on the shares ahead of the company reporting results of its fourth quarter on Tuesday, August 6. The firm expects demand for healthcare professionals, which represents approximately 90% of Adtalem’s enrollment, will continue to outpace supply for the foreseeable future and sees stronger year-over-year comps in FY25, the analyst tells investors in a preview note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Questions or Comments about the article? Write to editor@tipranks.com